Saudi Tibbiyah forms JV with BGI Almanahil to

Arabian Worldwide Healthcare Holding Firm (“Tibbiyah”), a number one built-in healthcare options supplier in Saudi Arabia, immediately introduced a definitive Joint Enterprise Settlement with BGI Almanahil Well being for Medical Companies, a subsidiary firm of BGI Well being (HK) Co., Ltd, within the formation and operation of a restricted legal responsibility firm to be referred to as Saudi Superior Medical Lab LIMITED (“SAMLL”) in Saudi Arabia. 

The brand new firm, owned 50% by BGI Almanahil and 50% by Tibbiyah, will present scientific laboratory testing and bio-information companies to hospitals, analysis institutes, and medical facilities and clinics for each private and non-private sectors. 

The CEO of Al Faisaliah Group, Mr. Ziad Al Tunisi, mentioned on the signing ceremony on July 26, “We’re delighted to announce this signing of Tibbiyah-BGI Almanahil Three way partnership Settlement and imagine it’ll strengthen Tibbiyah’s place as a powerful participant within the underserved extremely specialised scientific laboratory testing KSA healthcare market and reinforce its standing as a number one diversified healthcare firm.”

“This partnership combines the experience and expertise of two high-quality Healthcare suppliers, creating new alternatives to additional develop and develop our healthcare companies within the Kingdom, and delivers Tibbiyah technique to enter into engaging healthcare market segments which have sturdy fundamentals conducive to development and as one of many essential gamers within the Kingdom Healthcare Sector,” Mr. Ziad Al Tunisi mentioned.

The CEO of BGI Group, Dr. Yin Ye, mentioned, “The pandemic has posed an amazing problem to human society. Nevertheless, some may additionally develop true friendship by their shared experiences. In 2020, BGI assisted the Saudi Ministry of Well being to ascertain 5 ‘Huo-Yan’ laboratories throughout the Kingdom inside two months, and accomplished greater than 18 million PCR checks previously two years. We imagine that by working collectively, we are able to apply essentially the most superior genetic expertise to learn the well being of the folks, not solely in Saudi Arabia but in addition within the Center East in the long run. I’m satisfied that we are going to obtain this objective collectively.”

The CEO of BGI Genomics, Mr. Zhao Lijian mentioned, “With the benefits of each events, I imagine that SAMLL will turn into essentially the most superior and aggressive unbiased scientific laboratory, which can higher serve the sufferers and purchasers, keep the best high quality requirements, repeatedly introduce new scientific testing companies and medical expertise to the Kingdom Healthcare Sector.”

About BGI Genomics 

BGI Genomics (300676.SZ), headquartered in Shenzhen China, is the world’s main supplier of genomic sequencing and proteomic companies. We allow scientists and researchers to achieve their full potential by offering them with totally built-in genomic sequencing, proteomic companies, and high-quality options throughout a variety of functions. Our companies cowl greater than 100 nations and areas, involving greater than 2,300 medical establishments.